Orasis Pharmaceuticals

On Wednesday, our team will be in Indianapolis to attend the American Academy Of Optometry's #Academy24 Annual Meeting.     We are looking forward to connecting with #Optometry professionals from across the country to discuss the latest treatment options for patients living with #Presbyopia. Stop by booth #100 to learn more!    See you soon!    #Orasis 

We’re thankful we had the opportunity to attend the American Academy of Ophthalmology’s Annual Meeting in Chicago. Over the past few days, we heard from experts across the ophthalmology sector and gathered valuable feedback on our launch preparations. These meetings are a crucial time for us to collaborate as a team and strengthen our shared vision of supporting patients living with presbyopia. #AAO2024 #Presbyopia #Orasis #Ophthalmology

Presbyopia can turn simple tasks into frustrations, leaving many patients desiring spontaneity and freedom rather than the hassle of fumbling for their specs. At Orasis, we understand these challenges and remain dedicated to providing innovative treatment options that will empower patients to regain clarity and confidence in their daily lives. #ReshapingVisionPossibilities #Presbyopia #BreakFromReaders

We’re at the American Academy of Ophthalmology's Annual Meeting! We’re looking forward to Dr. Jennifer Loh's presentation tomorrow where she will be sharing the latest trial data behind our treatment for presbyopia. Join us to learn more.    #AAO2024 #Presbyopia #Orasis #Ophthalmology 

Heading to Chicago? The Orasis team will be at the American Academy of Ophthalmology’s Annual Meeting. We can’t wait to connect with leaders in #Ophthalmology and #EyeCare as we prepare for the commercial launch of our presbyopia treatment. See you in Chicago! #AAO2024 #Presbyopia #Orasis

Today, we are thrilled to announce the signing of an exclusive licensing agreement with Optus Pharmaceuticals, a Korean-based pharmaceutical company specializing in total eye care solutions. This partnership will strengthen our ability to bring our presbyopia treatment to more patients and define what’s next in vision care. Learn more about this significant milestone: https://lnkd.in/e7Jpesrx #News #InvestorNews #Ophthalmology #Optometry #Orasis #ReshapingVisionPossibilities  

Today, we give a warm welcome to our new Vice President of Quality and Operations, Sam Fakhoury. Sam joins us with deep expertise in operations, regulatory compliance, and quality systems, as well as over 20 years of medical device and pharma experience. We are excited to have him join our team! Read more: https://lnkd.in/en22Ty7Z #NewHire #Optometry #Orasis #Ophthalmology #ReshapingVisionPossibilities

Please join us in welcoming Jeff Francis, our new Vice President of Sales. Jeff is a seasoned industry leader with extensive experience in business development, commercial execution, and adaptive leadership across high-growth organizations. We look forward to seeing his expertise in action as we continue to challenge the status quo. Read more: https://lnkd.in/en22Ty7Z #NewHire #Optometry #Orasis #Ophthalmology #ReshapingVisionPossibilities

We are excited about this transformative partnership. Together, we can pioneer advancements in presbyopia care to enhance patient lives.     #News #InvestorNews #Ophthalmology #Optometry #Orasis #ReshapingVisionPossibilities